Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway

This study would suggest that Res and its combination with AR and CXCR4 antagonists can be used in order to suppress the metastatic behaviors of prostate cancer.
Source: The Journal of Steroid Biochemistry and Molecular Biology - Category: Biochemistry Source Type: research